<DOC>
	<DOCNO>NCT00608543</DOCNO>
	<brief_summary>Our target population adequately treat one three selective serotonin reuptake inhibitor ( SSRIs ; escitalopram , citalopram , sertraline ) least 8-12 week continue experience symptom depression prompt seek additional treatment . Escitalopram , citalopram , sertraline select use study among commonly select SSRIs associate reduced likelihood drug-drug interaction aripiprazole . After completion screen process , eligible participant augment aripiprazole ( 5 , 10 , 15 mg ) 6 week . Participants continue SSRI treatment prescribe physician , conjunction study participation . Symptom severity assess weekly basis , cognitive psychosocial function assess pre- post-augmentation . We hypothesize aripiprazole augmentation associate reduction symptom severity , improved performance measure psychosocial cognitive function .</brief_summary>
	<brief_title>Aripiprazole Augmentation SSRI Therapy Treatment Refractory Depression</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Depressive Disorder , Treatment-Resistant</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>Age 1865 Primary diagnosis Major Depressive Disorder ( MDD ) Completion least 812 week ( longer 6 month ) treatment escitalopram , citalopram , sertraline , least 6 week adequate dose ( i.e. , 20 mg escitalopram ; 40 mg citalopram ; 150 mg sertraline ) Hamilton Rating Scale Depression , 17item ( HRSD17 ) score less equal 14 and/or Clinical Global Impression Severity ( CGIS ) score less equal 3 Selfreported difficulty cognition and/or concentration , Inventory Depressive Symptomatology ClinicianRated , 30item ( IDSC30 ) item # 16 ( Concentration Decision Making ) score less equal 2 Ability read write English ( require instruction cognitive test several questionnaire available English ) Presence untreated unstable comorbid medical condition base physician information evidence examination , hypertension , diabetes , hypothyroidism . Presence known cardiovascular disease seizure disorder . Presence primary psychiatric disorder condition ( include depression due medical condition , currently suicidal high suicide risk , current past psychotic disorder type , bipolar disorder ( I , II , Not Otherwise Specified [ NOS ] ) , schizophrenia , schizoaffective disorder , anorexia , bulimia , obsessive compulsive disorder , alcohol substance abuse dependence within last 6 month ) Presence organic brain injury dementia , base cutoff score &lt; 20 Mini Mental Status Examination ( MMSE ) . Concomitant pharmacological psychotherapeutic treatment ( addition one SSRI describe Inclusion Criteria ) include limited anxiolytic , neuroleptic , mood stabilizer Hospitalization mental illness within past year . For woman , currently pregnant plan become pregnant next year .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>cognitive function</keyword>
	<keyword>psychosocial function</keyword>
	<keyword>augmentation</keyword>
	<keyword>treatment refractory depression</keyword>
</DOC>